Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes
© Fu et al; licensee BioMed Central Ltd. 2006
Received: 26 April 2006
Accepted: 19 July 2006
Published: 19 July 2006
Resistin is secreted from adipocytes, and high circulating levels have been associated with obesity and insulin resistance. To investigate whether resistin could exert autocrine effects in adipocytes, we expressed resistin gene in 3T3-L1 fibroblasts using a lentiviral vector, and selected several stably-transduced cell lines under blasticidin selection.
We observed that 3T3-L1 adipocytes expressing resistin have a decreased gene expression for related transcriptional factors (CCAAT/enhancer binding protein α(C/EBPα) , peroxisome proliferator-activated receptor gamma (PPARγ), and adipocyte lipid binding protein (ALBP/aP2) which is one of target genes for the PPARγ during adipocyte differentiation,. Overexpression of resistin increased the levels of three proinflammatory cytokines, tumor necrosis factor alpha (TNFα), interleukin 6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1), which play important roles for insulin resistance, glucose and lipid metabolisms during adipogenesis. Furthermore, overexpressing resistin in adipocytes inhibits glucose transport 4 (GLUT4) activity and its gene expression, reducing insulin's ability for glucose uptake by 30 %.
In conclusion, resistin overexpression in stably transduced 3T3-L1 cells resulted in: 1) Attenuation of programmed gene expression responsible for adipogenesis; 2) Increase in expression of proinflammatory cytokines; 3) Decrease in insulin responsiveness of the glucose transport system. These data suggest a new role for resistin as an autocrine/paracrine factor affecting inflammation and insulin sensitivity in adipose tissue.
Insulin resistance is a characteristic feature of Metabolic Syndrome and Type 2 Diabetes, and involves target tissues such as fat, liver, and skeletal muscle. The pathogenic mechanisms that impair insulin action in these tissues, and the factors responsible for the development of the Metabolic Syndrome trait cluster have not been fully elucidated. However, over the past decade, it has become clear the adipose tissue plays a central role in these processes. Adipocytes secret numerous factors, collectively referred to as adipocytokines, which circulate in blood and act on distal tissues to influence food intake, energy expenditure, and carbohydrate and lipid metabolism [1, 2]. However, there is a relative paucity of data regarding mechanisms regulating adipocytokine secretion in adipose tissue. Resistin is an example of an important adipocyte secreted protein [3, 4], and elevated resistin levels in adipose tissues and serum are observed in both genetic and diet-induced obesity and insulin resistance in animal models [5, 6]. Resistin administration or hyperresistinemia impairs glucose tolerance and induces hepatic insulin resistance [7, 8], whereas mice deficient in resistin are protected from obesity-associated insulin resistance . Hence, resistin has been proposed as a link between obesity, insulin resistance, and hyperglycemia.
Our understanding of resistin's role in metabolism has advanced primarily by studying its direct effects on skeletal muscle and liver tissues and related cultured cell systems, while less is understood regarding autocrine/paracrine effects of resistin in regulating adipocyte biology and adipocytokine secretion. To address this question, we established stably transduced 3T3-L1 fibroblast cell lines using a lentiviral vector to hyperexpress resistin. We observed that overexpression of resistin impairs the insulin-stimulable glucose transport system by suppressing GLUT4 expression and modulates the secretion of inflammatory cytokines via an autocrine/paracrine mechanism.
Mouse 3T3-L1 fibroblast cells were purchased from American Type Culture Collection (Manassas, VA). Tissue culture media were purchased from Life Technologies (Gaithersburg, MD). Insulin, dexamethasone (Dex) and isobutyl-methylxanthine (IBMX) were purchased from Sigma (St. Louis, MO). LacZ staining kit was purchased from Stratagene (San Diego, CA). RNA isolation solution was purchased from Biotecx Laboratory (Houston, TX). Horseradish peroxidase (HRP)-conjugated antibodies to the V5 epitope were purchased from Invitrogen (Carlsbad, CA), resistin antibody from Chemicon International (Temecula, CA) and TNFα, IL-6, IL-10 and MCP-1 antibodies from Santa Cruz Biotechnology (Santa Cruz, CA). 2-deoxy-D-[3H] and L-[1-3H] glucose were purchased from Amersham (Arlington Heights, IL). Unless otherwise specified, all other reagents were purchased from Sigma.
Recombinant lentiviruses and lentiviral transduced cell lines
Fusion cDNAs, containing the full length of mouse resistin coding sequence and a V5 epitope tag, were cloned into a ViraPower-CMV vector (Invitrogen). The recombinant lentiviral plasmids and a control LacZ gene construct were transfected into HEK293 cells. Western blot and X-gal staining were performed to confirm that the HEK293 cell transfection was successful and infectious virus particles were produced. To establish stable 3T3-L1 cell lines which express resistin or LacZ genes, recombinant resistin or LacZ lentiviral stocks were used to infect 3T3-L1 cells with Polybrene (Specialty Media, Phillipsburg, New Jersey) at a final concentration of 6 μg/ml. Forty-eight hours post-transduction, these cells were placed under blasticidin selection (10 μg/ml) for 20 days. Western blot analyses were performed to test for stable resistin or LacZ gene expression in the selected cell lines after antibiotic selection.
Cell culture and stimulation
3T3-L1 fibroblasts or transduced cell lines were grown and differentiated into adipocytes in 100-mm culture dishes, as described by Frost and Lane . Briefly, cells were grown to 100% confluence in Dulbecco's minimal essential medium (DMEM) containing 25 mM glucose and 10% calf serum at 37°C in a humidified atmosphere containing 5% CO2. Two days after full confluence, cells were differentiated via incubation in DMEM containing 25 mM glucose, 0.5 mM isobutylmethylxanthine (IBMX), 1 μm dexamethasone (Dex), 10 μg/ml insulin, and 10% FBS for 3 days and then for 2 days in DMEM containing 25 mM glucose, 10 μg/ml insulin, and 10% FBS. Thereafter, cells were maintained in and refed every 2 days or 3 days with DMEM, 25 mM glucose, and 10% FBS until used in the experiments 10–14 days after initiation of the differentiation protocol, when between 80 and 90% of the cells exhibited the adipocyte phenotype. In differentiated adipocytes, various experiments involved stimulation with insulin (10μg/ml) for 30 min at 37°C.
Glucose transport activity assays
For measurement of glucose transport activity, adipocyte cells or conditioned medium cultured cells (two days prior the assays) were washed three times with transport buffer (pH7.4), consisting of 20 mM HEPES, 120 mM NaCl, 1.2 mM MgSO4, 2 mM CaCl2, 2.5 mM KCl, 1 mM NaH2PO4, and 1 mM sodium pyruvate, and incubated in this buffer for an additional 30 min in the absence (basal) and presence of a insulin concentration (100 nM) at 37°C. Glucose transport was assayed in monolayers as initial rates of 2-deoxy glucose uptake as we have previously described . In these experiments, the distribution space of radiolabeled L-glucose was used to correct for nonspecific carryover of radioactivity with the cells and uptake of hexose by simple diffusion.
Western blot analysis
Adipocytes were harvested from the culture plates with cell lysis buffer (1 × PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS) containing freshly added protease inhibitor cocktail (Sigma). Twenty-five μg of protein per lane and known molecular weight markers from Bio-Rad (Hercules, CA) were separated by SDS-polyacrylamide gel electrophoresis. Proteins were electrophoretically transferred onto nitrocellulose membranes and incubated overnight at 4°C with blocking solution (5% nonfat milk in TBS). The blocked membranes were separately incubated with the anti-resistin, -TNFα, -IL-6, -IL-10 or -MCP-1 antibodies or the horseradish peroxidase (HRP)-conjugated V5 epitope antibody (1:1000 dilution with 1% nonfat milk in TBS) for 1 hour at room temperature, and washed three times with TBS buffer containing 0.1% Tween 20 for 15 minutes at room temperature with shaking. The second antibody conjugated with horseradish peroxidase (HRP) (Santa Cruz Biotechnology) against to the premier antibody was added, incubated, and washed as described above for the first antibody. Immunodetection analyses were accomplished using the Enhance Chemiluminescence Kit (New England Nuclear Life Science Products, Boston, MA).
ELISA assays of resistin in 3T3-L1 cell culture medium samples were analyzed using a resistin ELISA kit from LINCO Research (St. Charles, MO). The assays were performed according to the manufacture's protocol.
Real time QPCR analysis
About 5 μg of the total RNA was converted to first strand cDNAs in 20 μl reactions using random primers (Gibco BRL). For each quantitative PCR experimental set, the target gene primers (see bellow) were utilized to amplify a 10-fold serial diluted gene products (10 to 1012) to make a linear standard curve for each individual target gene. For an endogenous standard, 18S rRNA primers (5'-AAT TTG ACT CAA CAC GGG AAA CCT CAC-3' and 5'-CAG ACA AAT CGC TCC ACC AAC TAA GAA C-3') were simultaneously used for amplification from 1 μl first strand cDNAs in each 20 μl reaction tube; this allowed for normalization of cDNA loading and relative mRNA units in each of reactions.
QPCRs were performed using a Mx3000P™ Real-Time PCR System and a Brilliant SYBR Green QPCR Master Mix buffer (Stratagene) containing 100 mM KCl, 40 mM Tris-HCl, 0.4 mM of each dNTP, 2.5 mM MgCl2, SYBR Green I, SureStart Taq DNA polymerase (50 units/ml) with hot start capability, and 20 nM of fluorescein for experimental plate well factor collection on the Mx3000P™ Real-Time PCR System. A passive diluted reference dye (ROX) was also added to each tube (30 nM) to compensate for non-PCR related variations in fluorescence. The concentrations of the gene primers for ALBP/aP2 (5'-TAC TGG GCC AGG AAT TTG AC-3' and 5'-GTG GAA GTG ACG CCT TTC AT-3'); PPARγ (5'-TTT TCA AGG GTG CCA GTT TC-3' and 5'-AAT CCT TGG CCC TCT GAG AT-3'); C/EBPα (5'-GCT GGA GTT GAC CAG TGA CA-3' and 5'-AAA CCA TCC TCT GGG TCT CC-3'); GLUT 4 (5'-GAT TCT GCT GCC CTT CTG TC-3' and 5'-ATT GGA CGC TCT CTC TCC AA-3') were 500 nM for each primer and 1 μl first strand cDNAs for each real-time QPCR reaction performed in a volume of 20 μl. The thermal cycling program was 3 min at 95°C for enzyme activation (allowing an automated hot start PCR), 45 cycles of denaturation for 30s at 95°C, 30s annealing at 60°C, and 30s extension at 72°C.
Melting curve analysis was performed to confirm the real-time QPCR products. The amplified products were denaturated and reannealed at different temperature points to detect their specific melting temperature.
Experimental results were shown as the mean ± se. Statistical analyses were performed by unpaired Students' T-test assuming unequal variance unless otherwise indicated. Significance was defined as the P < 0.05.
Generation of recombinant resistin lentiviruses and lentiviral transduced stable cell lines
To establish stable 3T3-L1 fibroblast cell lines which overexpress resistin or LacZ genes, recombinant resistin or LacZ lentiviral stocks purified from HEK293 cells were used to infect 3T3-L1 fibroblasts. Forty-eight hours post-transduction, these cells were placed under blasticidin selection (10 μg/ml) for 20 days. The tests for stable recombinant resistin or LacZ gene expression were performed using an antibody against the V5 epitope tags in these recombinant proteins after antibiotic selection by Western blot analyses (Fig. 1B). We also examined the secretion of recombinant resistin proteins in the cell culture media from the selected resistin transduced cell lines after adipocyte differentiation (day 12, see below). Both endogenous native resistin as well as exogenous lentivirus-transduced resistin containing the V5 tag were readily detected in the media of fully differentiated adipocytes as shown in Figure 1C. Thus, cells transduced with the resistin lentivirus both synthesized and secreted resistin as a consequence of transgene introduction. Endogenous resistin levels in the media from these resistin transduced cell lines were comparable to levels observed in media from control cells. The overall secretion of resistin (endogenous + exogenous) was approximately 2–4 fold greater (95 ng/ml to 195 ng/ml by ELISA, data not shown) in the stable resistin-overexpressing cell lines compared with LacZ controls.
Resistin hyperexpression in 3T3-L1 adipocytes
Effects of resistin overexpression on insulin sensitivity and GLUT4 expression
This effect on the insulin-stimulated glucose uptake was also observed when we used conditioned media from resistin-overexpressing cells versus media from LacZ-expressing cells to treat non-transduced 3T3-L1 adipocytes (Figure 3B). The adipocytes were cultured in conditioned media for two days prior the glucose transport assays. The maximal insulin-stimulated glucose transport rate was significantly decreased 50% (p < 0.05) in the cells cultured with the medium from resistin-transduced adipocytes (Bar 4, Resistin(m) + Insulin), compared to that from LacZ-transduced adipocytes (Bar 3, Control(m) + Insulin). Similar results were observed when using non-conditioned medium as a control; insulin-stimulated glucose transport was comparable in cells exposed to non-conditioned media and conditioned media from LacZ expressing cells, while the insulin action was reduced by 42% to 49% when cells were treated with conditioned media from resistin-overexpressing cells or purified resistin protein (data not shown).
To identify whether diminished activity of the insulin-responsive glucose transport system was associated with a decrease in GLUT4 gene expression, we measured GLUT 4 mRNA in both resistin overexpressing and control LacZ adipocytes. Figure 3C shows that GLUT4 mRNA levels were reduced by 51% in cells overexpression resistin compared with LacZ-transduced cells, and that the decline in GLUT4 mRNA levels was observed over days 5 to 9 during differentiation.
Effects of resistin overexpression on cytokine production
Resistin is one of multiple adipocytokines secreted by adipose tissue, and has been shown to modulate both glucose and lipid metabolism in vivo and in vitro. In animal models, it has been recently reported that mice with chronic hyperresistinemia have elevated glucose production due to the increased expression of hepatic phosphoenolpyruvate carboxykinase (PEPCK) and hepatic insulin resistance . In L6 rat skeletal muscle cells, it has been shown that resistin does not alter insulin receptor signaling but does affect insulin-stimulated glucose uptake, presumably by decreasing the intrinsic activity of cell surface glucose transporters . However, the mechanisms by which resistin could modulate insulin sensitivity remain obscure, and data addressing whether resistin can affect insulin action in adipocytes are lacking. The current studies demonstrate that overexpression of resistin in 3T3-L1 adipocytes, in conjunction with increased secretion of resistin into the surrounding media, are able to: (i) affect the expression pattern of key transcription factors during adipogenesis and, in fully differentiated cells, (ii) impair insulin's ability to stimulate glucose transport concomitant with a reduction in GLUT4 gene expression and (iii) augment production of inflammatory cytokines, TNFα and IL-6. These data indicate that resistin could function as a powerful autocrine/paracrine factor in adipose tissue regulating insulin action and adipocytokine production.
Adipogenesis from fibroblast precursors follows a highly ordered and well characterized temporal sequence. The first step is growth arrest of proliferating preadipocytes, followed by the coordinated sequential expression of key transcription factors that direct the adipogenic program. It has been shown that PPARγ and C/EBPα are key transcriptional factors for initiating adipocyte differentiation [22, 23], and positively regulate each other's expression. However, PPARγ is felt to play a directorial role in the adipogenic hierarchy of transcription factors, while C/EBPα promotes specific aspects of the adipocyte phenotype including insulin sensitivity and lipid accumulation . In the current study, resistin overexpression reduced mRNA levels for PPARγ and C/EBPα during adipogenesis, although no dramatic morphologic changes were observed in these cells during adipogenesis and lipid accumulation was not affected. Nevertheless, we did observe important functional defects in resistin overexpressing cells. PPARγ and C/EBPα direct the expression of a multiplicity of genes responsible for the fully-differentiated adipocyte phenotype, and two key functional proteins include ALBP/aP2 and GLUT4 . With the expression of these proteins, cells acquire a capacity for insulin-stimulated glucose transport, and lipid droplets begin to appear in the cytoplasm and over time coalesce into fewer major droplets in the cells. The expression of both ALBP/aP2 mRNA and GLUT4 mRNA were suppressed in the resistin lentivirus-transduced cells compared with LacZ transduced controls. While the suppression of aP2 mRNA did not lead to measurable differences in cellular lipid content, the reduction in GLUT4 mRNA was accompanied by a marked attenuation in insulin stimulated glucose transport activity. Thus, resistin overexpression and hypersecretion induced insulin resistance in adipocytes. This effect of resistin overexpression was observed in three separate clones of stably-transduced cells and, therefore, appeared to be independent of the site of genomic integration.
Three proinflammatory cytokines produced by adipose tissue are TNFα, IL-6 and MCP-1. While these cytokines have been shown to modulate glucose homeostasis and lipid metabolism and to induce insulin resistance [19, 20, 25], the factors that regulate synthesis and secretion in adipose tissue are unknown. Our data demonstrated that resistin overexpression in adipocytes led to increased production of these proinflammatory cytokines. Interestingly, overexpression of resistin led to an inhibition of the production of IL-10, which limits inflammatory responses and promotes insulin sensitivity and is also down-regulated in metabolic syndrome . These data are consistent with the idea that resistin secreted from adipocytes acted in an autocrine/paracrine manner to augment cytokine production. Regarding effects of resistin overexpression on insulin-stimulated glucose transport, we are unable to say whether this is due to a direct effect of resistin, or was secondarily caused by resistin-mediated hypersecretion of TNFα, IL-6 and MCP-1 or hyposecretion of IL-10.
Regardless of whether insulin resistance was induced directly by resistin or via increased secretion of cytokines, the data indicate that resistin, TNFα, IL-6 and MCP-1 are capable of functioning in an autocrine/paracrine manner to regulate adipocyte cell biology and proinflammatory cytokine secretion. Conditioned media from the resistin overexpressing cells was able to induce insulin resistance in LacZ transduced or non-transduced adipocytes, and contained only 2–4 times more resistin (from endogenous and transgene origin) than LacZ transduced control cells (endogenous origin only), which is within the physiological range of resistin production. Thus, the observed effects in cultured adipocytes could feasibly be relevant to events occurring in intact tissue. Our data, for the first time, demonstrate resistin's role in adipose tissue as a potential autocrine mediator of insulin resistance and inflammation that accompanies enlarging fat cell size and progressive obesity.
Adiponectin is another important adipocytokine that, in contradistinction to resistin, is secreted in lesser amounts with increments in fat cell size and acts to increase insulin sensitivity. For example, we have previously shown that adiponectin promotes adipogenesis, lipid accumulation, and insulin sensitivity when secreted into the media of cultured 3T3-L1 adipocytes . Given the inverse relationship of adiponectin and resistin with respect to the influence of fat cell size on secretion and effects on insulin sensitivity, we examined whether overexpression of resistin or adiponectin would regulate each other in the transduced adipocytes. We observed that overexpression of either resistin or adiponectin did not regulate secretion of the other adipocytokine (data not shown). Therefore, while there could exist coordinate regulation of resistin and adiponectin, this will be mediated by a third factor that is independent of these adipocytokines and their action pathways.
We are grateful to the support of core facilities (Director, Dr. Barbara Gower) in the UAB Clinical Nutrition Research Unit (P30 DK-56336). This work was supported by grants from the National Institutes of Health (DK-38765; PO1 HL-55782), and by the Merit Review Program of the Department of Veterans Affairs.
- Havel P: Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Current Opinion in Lipidology. 2002, 13: 51-59. 10.1097/00041433-200202000-00008.View ArticleGoogle Scholar
- Beltowski J: Adiponectin and resistin – new hormones of white adipose tissue. Med Sci Monit. 2003, 9: 55-61.Google Scholar
- Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature. 2001, 409: 307-312. 10.1038/35053000.View ArticleGoogle Scholar
- Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA: A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA. 2001, 98: 502-506. 10.1073/pnas.98.2.502.View ArticleGoogle Scholar
- Kim KH, Lee K, Moon YS, Sul HS: A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001, 276: 11252-11256. 10.1074/jbc.C100028200.View ArticleGoogle Scholar
- Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE, Ahima RS: Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes. 2004, 53: 1671-1679.View ArticleGoogle Scholar
- Rajala MW, Obici S, Scherer PE, Rossetti L: Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest. 2003, 111: 225-230. 10.1172/JCI200316521.View ArticleGoogle Scholar
- Satoh H, Nguyen MTA, Miles PDG, Imamura T, Usui I, Olefsky JM: Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest. 2004, 114: 224-231. 10.1172/JCI200420785.View ArticleGoogle Scholar
- Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA: Regulation of fasted blood glucose by resistin. Science. 2004, 303: 1195-1198. 10.1126/science.1092341.View ArticleGoogle Scholar
- Frost S, Lane M: Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biol Chem. 1985, 260: 2646-2652.Google Scholar
- Mayor P, Maianu L, Garvey WT: Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes: Effects on glucose transporter gene expression. Diabetes. 1992, 41: 274-285.View ArticleGoogle Scholar
- Green H, Kehinde O: Sublines of mouse 3T3 cells that accumulate lipid. Cell. 1974, 1: 113-116. 10.1016/0092-8674(74)90126-3.View ArticleGoogle Scholar
- Green H, Kehinde O: An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell. 1975, 5: 19-27. 10.1016/0092-8674(75)90087-2.View ArticleGoogle Scholar
- Green H, Kehinde O: Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell. 1976, 7: 105-113. 10.1016/0092-8674(76)90260-9.View ArticleGoogle Scholar
- Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM: Transcriptional regulation of adipogenesis. Genes Dev. 2000, 14: 1293-1470.Google Scholar
- Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM: mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994, 8: 1224-1234.View ArticleGoogle Scholar
- Rosen ED, Scarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM: PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell. 1999, 4: 611-617. 10.1016/S1097-2765(00)80211-7.View ArticleGoogle Scholar
- Pravenec M, Kazdova L, Landa V, Zidek V, Mlejnek P, Jansa P, Wang J, Qi N, Kurtz TW: Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem. 2003, 278: 45209-45215. 10.1074/jbc.M304869200.View ArticleGoogle Scholar
- Sethi JK, Hotamisligil GS: The role of TNFα in adipocyte metabolism. Cell Develop Biol. 1999, 10: 19-29. 10.1006/scdb.1998.0273.View ArticleGoogle Scholar
- Guerre-Millo M: Adipose tissue and adipokines: for better or worse. Diabetes & Metabolism. 2004, 30: 13-19.View ArticleGoogle Scholar
- Moon B, Kwan JJ, Duddy N, Sweeney G, Begum N: Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am Physi Endo Metabolism. 2003, 285: 106-115.Google Scholar
- Morrison RF, Farmer SR: Role of PPARγ in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis. J Biol Chem. 1999, 274: 17088-17097. 10.1074/jbc.274.24.17088.View ArticleGoogle Scholar
- Shao D, Lazar MA: Peroxisome proliferator activated receptor γ, CCAAT/enhancer-binding protein α, and cell cycle status regulate the commitment to adipocyte differentiation. J Biol Chem. 1997, 272: 21473-21478. 10.1074/jbc.272.34.21473.View ArticleGoogle Scholar
- Spiegelman BM, Choy L, Hotamisligil G, Graves RA, Tontonoz P: Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J Biol Chem. 1993, 268: 6823-6826.Google Scholar
- Sartipy P, Loskutoff DJ: Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A. 2003, 100: 7265-7270. 10.1073/pnas.1133870100.View ArticleGoogle Scholar
- Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, Nicoletti G, Giuglianoet D: Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab. 2003, 88: 1055-1058. 10.1210/jc.2002-021437.View ArticleGoogle Scholar
- Fu Y, Luo N, Klein RL, Garvey WT: Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res. 2005, 46: 1369-1379. 10.1194/jlr.M400373-JLR200.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.